Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71

Neurobiology of Disease

Volumn 43, Issue 1, 2011, Pages 134-141

  Miranda, Rubén ^a,b   Nudel, Uri ^c   Laroche, Serge ^a,b   Vaillend, Cyrille ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Dysbindin; Mdx mice; Neuroligin neurexin complex; Neurotransmitter release; Synaptic plasticity; Synaptic vesicle cycling

Indexed keywords

DYSTROPHIN; DYSTROPHIN 427; DYSTROPHIN 71; NEUROTRANSMITTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ELECTRON MICROSCOPY; HIPPOCAMPAL CA1 REGION; INTELLECTUAL IMPAIRMENT; MOUSE; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION;

ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DYSTROPHIN; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; NEURONAL PLASTICITY; PRESYNAPTIC TERMINALS; PROTEIN ISOFORMS; SYNAPTIC VESICLES;

EID: 79955968070     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.02.017     Document Type: Article

References (52)

1. Amiry-Moghaddam M., et al. Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience 2004, 129:999-1010.
2. Benson M.A., et al. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J. Biol. Chem. 2001, 276:24232-24241.
3. Blake D.J., Kröger S. The neurobiology of duchenne muscular dystrophy: learning lessons from muscle?. Trends Neurosci. 2000, 23:92-99.
4. Blake D.J., et al. Different dystrophin-like complexes are expressed in neurons and glia. J. Cell Biol. 1999, 147:645-658.
5. Bogdanik L., et al. Muscle dystroglycan organizes the postsynapse and regulates presynaptic neurotransmitter release at the Drosophila neuromuscular junction. PLoS ONE 2008, 3:e2084.
6. Brunig I., et al. GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA(A) receptors and gephyrin. J. Neurosci. 2002, 22:4805-4813.
7. Buckby L.E., et al. Network stability through homeostatic scaling of excitatory and inhibitory synapses following inactivity in CA3 of rat organotypic hippocampal slice cultures. Mol. Cell. Neurosci. 2006, 31:805-816.
8. Chen X.W., et al. DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release. J. Cell Biol. 2008, 181:791-801.
9. Daoud F., et al. Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions. PLoS ONE 2009, 4:e6574.
10. Daoud F., et al. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression. Hum. Mol. Genet. 2009, 18:3779-3794.
11. Desguerre I., et al. Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS ONE 2009, 4:e4347.
12. Dobrunz L.E., Stevens C.F. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 1997, 18:995-1008.
13. Edwards R.H. The neurotransmitter cycle and quantal size. Neuron 2007, 55:835-858.
14. Fradkin L.G., et al. The dystrophin Dp186 isoform regulates neurotransmitter release at a central synapse in Drosophila. J. Neurosci. 2008, 28:5105-5114.
15. Futai K., et al. Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin. Nat. Neurosci. 2007, 10:186-195.
16. Harris K.M., Sultan P. Variation in the number, location and size of synaptic vesicles provides an anatomical basis for the nonuniform probability of release at hippocampal CA1 synapses. Neuropharmacology 1995, 34:1387-1395.
17. Hopf F.W., Steinhardt R.A. Regulation of intracellular free calcium in normal and dystrophic mouse cerebellar neurons. Brain Res. 1992, 578:49-54.
18. Jancsik V., Hajós F. Differential distribution of dystrophin in postsynaptic densities of spine synapses. Neuroreport 1998, 9:2249-2251.
19. Karunanithi S., et al. Quantal size and variation determined by vesicle size in normal and mutant Drosophila glutamatergic synapses. J. Neurosci. 2002, 22:10267-10276.
20. Kim T.W., et al. Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11642-11644.
21. Knuesel I., et al. Altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur. J. Neurosci. 1999, 11:4457-4462.
22. Knuesel I., et al. Differential expression of utrophin and dystrophin in CNS neurons: an in situ hybridization and immunohistochemical study. J. Comp. Neurol. 2000, 422:594-611.
23. Lidov H.G., et al. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 1990, 348:725-728.
24. Miranda R., et al. Reorganization of inhibitory synapses and increased PSD length of perforated excitatory synapses in hippocampal area CA1 of dystrophin-deficient mdx mice. Cereb. Cortex 2009, 19:876-888.
25. Morris D.W., et al. Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility. Biol. Psychiatry 2008, 63:24-31.
26. Mozhayeva M.G., et al. Development of vesicle pools during maturation of hippocampal synapses. J. Neurosci. 2002, 22:654-665.
27. Neuman S., et al. The dystrophin / utrophin homologues in Drosophila and in sea urchin. Gene 2001, 263:17-29.
28. Neuman S., et al. The Drosophila homologue of the dystrophin gene-introns containing promoters are the major contributors to the large size of the gene. FEBS Lett. 2005, 579:5365-5371.
29. Nico B., et al. Altered blood-brain barrier development in dystrophic MDX mice. Neuroscience 2004, 125:921-935.
30. Nikonenko A.G., Skibo G.G. Technique to quantify local clustering of synaptic vesicles using single section data. Microsc. Res. Tech. 2004, 65:287-291.
31. Numakawa T., et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 2004, 13:2699-2708.
32. Olsen O., et al. Synaptic transmission regulated by a presynaptic MALS/Liprin-alpha protein complex. Curr. Opin. Cell Biol. 2006, 18:223-227.
33. Perronnet C., Vaillend C. Dystrophins, utrophins and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies. J. Biomed. Biotechnol. 2010, 2010:849426.
34. Pilgram G.S., et al. The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol. Neurobiol. 2010, 41:1-21.
35. Pozzo-Miller L.D., et al. Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J. Neurosci. 1999, 19:4972-4983.
36. Qu L., et al. Synapse-to-synapse variation in mean synaptic vesicle size and its relationship with synaptic morphology and function. J. Comp. Neurol. 2009, 514:343-352.
37. Sarig R., et al. Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development. Hum. Mol. Genet. 1999, 8:1-10.
38. Savtchenko L.P., Rusakov D.A. The optimal height of the synaptic cleft. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1823-1828.
39. Schikorski T., Stevens C.F. Quantitative ultrastructural analysis of hippocampal excitatory synapses. J. Neurosci. 1997, 17:5858-5867.
40. Schikorski T., Stevens C.F. Morphological correlates of functionally defined synaptic vesicle populations. Nat. Neurosci. 2001, 4:391-395.
41. Sillitoe R.V., et al. Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy. J. Neurosci. 2003, 23:6576-6585.
42. Südhof T.C. The synaptic vesicle cycle revisited. Neuron 2000, 28:317-320.
43. Sugita S., et al. A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol. 2001, 154:435-445.
44. Talbot K., Cho D.S., Ong W.Y., et al. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum. Mol. Genet. 2006, 15:3041-3054.
45. Tanaka H., et al. Molecular modification of N-cadherin in response to synaptic activity. Neuron 2000, 25:93-107.
46. Tyler W.J., Pozzo-Miller L.D. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J. Neurosci. 2001, 21:4249-4258.
47. Vaillend C., et al. Facilitated NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 area of dystrophin-deficient mice. Synapse 1999, 33:59-70.
48. Vaillend C., et al. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse. Neurobiol. Dis. 2004, 17:10-20.
49. Vaillend C., et al. Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse. Mol. Ther. 2010, 18:1683-1688.
50. Van der Plas M.C., et al. Dystrophin is required for appropriate retrograde control of neurotransmitter release at the Drosophila neuromuscular junction. J. Neurosci. 2006, 26:333-344.
51. Wairkar Y.P., et al. Synaptic defects in a Drosophila model of congenital muscular dystrophy. J. Neurosci. 2008, 28:3781-3789.
52. Wu X., et al. The origin of quantal size variation: vesicular glutamate concentration plays a significant role. J. Neurosci. 2007, 27:3046-3056.